RenaissanceRe (NYSE:RNR) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday.
According to Zacks, “RenaissanceRe’s fourth-quarter earnings per share of $1.05 handily beat the Zacks Consensus Estimate by 38%, but declined 64% year over year due to higher expenses. The company’s consistent premium growth bolsters the revenue base. Its inorganic growth impresses. It's healthy balance sheet also remains a major positive. Although its shares have underperformed the industry in a year’s time, solid fourth-quarter results and strong fundamentals are expected to favor the stock going forward. Its weak investment portfolio has been a concern. Continuous catastrophe losses also remain a major headwind. Moreover, the company’s bottom line also suffers from continuously rising level of expenses. Increasing level of debt continues to weigh on RenaissanceRe’s margins. “
Several other equities analysts have also issued reports on the company. Wells Fargo & Co restated a “hold” rating and set a $125.00 target price on shares of RenaissanceRe in a research report on Wednesday, January 31st. UBS Group boosted their target price on RenaissanceRe from $135.00 to $144.00 and gave the stock a “neutral” rating in a research report on Monday, November 6th. Morgan Stanley decreased their target price on RenaissanceRe from $144.00 to $142.00 and set an “equal weight” rating for the company in a research report on Thursday, November 2nd. Citigroup upgraded RenaissanceRe from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $151.00 to $157.00 in a research report on Thursday, November 2nd. Finally, Keefe, Bruyette & Woods restated a “hold” rating and set a $136.00 target price on shares of RenaissanceRe in a research report on Monday, October 16th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $146.50.
RenaissanceRe (NYSE:RNR) last posted its earnings results on Wednesday, January 31st. The insurance provider reported $1.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.29. The company had revenue of $288.22 million during the quarter, compared to analyst estimates of $227.65 million. RenaissanceRe had a negative return on equity of 7.68% and a negative net margin of 10.57%. The company’s revenue for the quarter was up 31.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.66 EPS. equities research analysts expect that RenaissanceRe will post 9.88 EPS for the current fiscal year.
RenaissanceRe declared that its board has authorized a stock buyback plan on Friday, November 10th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the insurance provider to reacquire shares of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.
In other RenaissanceRe news, CEO Kevin Odonnell sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $131.65, for a total value of $658,250.00. Following the sale, the chief executive officer now owns 190,707 shares in the company, valued at approximately $25,106,576.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Sean G. Brosnan sold 1,391 shares of the business’s stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $135.73, for a total value of $188,800.43. Following the completion of the sale, the senior vice president now owns 8,405 shares in the company, valued at approximately $1,140,810.65. The disclosure for this sale can be found here. Insiders own 1.80% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Verition Fund Management LLC bought a new stake in RenaissanceRe in the 2nd quarter valued at approximately $383,000. Legal & General Group Plc lifted its stake in RenaissanceRe by 8.3% in the 3rd quarter. Legal & General Group Plc now owns 291,126 shares of the insurance provider’s stock valued at $39,353,000 after acquiring an additional 22,205 shares in the last quarter. Barings LLC bought a new stake in RenaissanceRe in the 3rd quarter valued at approximately $896,000. Zurich Insurance Group Ltd FI bought a new stake in RenaissanceRe in the 2nd quarter valued at approximately $830,000. Finally, Stifel Financial Corp lifted its stake in RenaissanceRe by 238.3% in the 3rd quarter. Stifel Financial Corp now owns 6,394 shares of the insurance provider’s stock valued at $864,000 after acquiring an additional 4,504 shares in the last quarter. Hedge funds and other institutional investors own 90.46% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/02/06/renaissancere-rnr-rating-increased-to-hold-at-zacks-investment-research.html.
RenaissanceRe Company Profile
RenaissanceRe Holdings Ltd. provides reinsurance and insurance coverages and related services to a range of customers. The Company’s products include property, casualty and specialty reinsurance and certain insurance products principally distributed through intermediaries. Its segments include Property; Casualty and Specialty, and Other category.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RenaissanceRe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenaissanceRe and related companies with MarketBeat.com's FREE daily email newsletter.